A guide to management of neuropsychiatric manifestations of Parkinson's disease

Rosa M. Molina Ruiz*, Andrew H. Evans, Dennis Velakoulis, Jeffrey C.L. Looi

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    2 Citations (Scopus)

    Abstract

    Objective: This clinical update review focuses on treatment approaches of neuropsychiatric manifestations in Parkinson's disease. Methods: We conducted a systematic search of the literature using Pubmed and selected recent and relevant papers for this review. Results: Neuropsychiatric symptoms in Parkinson's disease usually require optimization of levodopa therapy as a first step. Most psychotropic drugs can be used in Parkinson's disease, however there is still lack of an evidence base due to limited studies and difficulties in diagnosis of neuropsychiatric disorders. Non-pharmacological treatments have also proved effective in Parkinson's disease. Cognitive impairment requires special consideration. Conclusions: Management of neuropsychiatric manifestations in Parkinson's disease is complicated by the lack of evidence. Treatment should be individualized and benefits and risks must be balanced.

    Original languageEnglish
    Pages (from-to)534-537
    Number of pages4
    JournalAustralasian Psychiatry
    Volume24
    Issue number6
    DOIs
    Publication statusPublished - Dec 2016

    Fingerprint

    Dive into the research topics of 'A guide to management of neuropsychiatric manifestations of Parkinson's disease'. Together they form a unique fingerprint.

    Cite this